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Case 
 
An 82 year old lady originally presented to the acute general hospital with a 
small haemorrhagic cerebrovascular accident (stroke) complicated by flash 
pulmonary oedema (neurogenic) which was treated with high dose loop diuretics. 
She was a known case of hypertension and type 2 diabetes mellitus on aspirin, 
perindopril, metformin and gliclazide, naturally her antiplatelet having been 
withdrawn with this admission. There were no neurological sequelae to the stroke 
sustained, but she was left on 4mg bumetanide daily, despite rapid resolution of 
Citation: Aquilina N., Bugeja V., 
Bugeja G. (2018) A Case of 
Functional Hypoparathyoidism due 
to Hypomagnesaemia Leading to 
Hypocalcaemic Seizures.Open 
Science Journal 3(1)  
 
 
Received:  31st December 2017 
 
Accepted: 15th March 2018 
 
Published: 25th March 2018 
 
Copyright:© 2018 This is an 
open access article under the terms 
of the Creative Commons 
Attribution License, which permits 
unrestricted use, distribution, and 
reproduction in any medium, 
provided the original author and 
source are credited. 
 
Funding: The author(s) received 
no specific funding for this work 
 
Competing Interests: The 
author have declared that no 
competing interests exists. 
This case report describes an elderly lady who was maintained on 
a high dose of loop diuretics following resolution of her acute 
pulmonary oedema, which in turn led to wasting of calcium and 
magnesium at the nephron level. Her hypomagnesaemia further 
contributed to the hypocalcaemia by rendering ineffective the 
normal parathyroid negative feedback physiological response. 
This state of low calcium increased the neuromuscular 
excitability leading to myoclonic epilepsy which was resistant to 
benzodiazepines. Such hypocalcaemic tetany in this case would 
only be adequately addressed once the magnesium levels are 
repleted, as this would allow the parathyroid mechanism to 
function effectively and redress the calcium level as a result.	
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her flash pulmonary oedema, in view of the fact that a follow up echocardiogram 
showed mild left ventricular hypokinesia, to safeguard against recurrence of her 
pulmonary congestion. 
Following transfer to our facility at Karen Grech Rehabilitation Hospital for 
post – acute care, she developed generalized, coarse, myoclonic jerking - involving 
head titubation, jaw jerking and repetitive clonic movements of all limbs – 
occurring rather acutely a couple of weeks after her arrival. This was initially 
treated with rectal diazepam, to no significant effect, whilst an urgent CT 
(computed tomogram) brain scan came back unremarkable (showing good 
resolution of her original intracranial bleed). The persistent myoclonic activity 
was very disruptive, even during sleep. A panel of blood tests including calcium, 
phosphate and magnesium was taken the following day, showing very low 
magnesium (0.32 mmol/L), a similarly low corrected calcium (1.75 mmol/L) with 
a marginally elevated phosphate (1.42 mmol/L), whilst she was also 
hyponatraemic (128 mmol/L) and mildly hypokalaemic (3.3mmol/L). 
Unfortunately we were unable to take a parathyroid hormone (PTH) level for 
logistical reasons, whereas 24 hour urine studies for electrolytes were not carried 
out in the clinical setting as they were perceived to be an academic exercise vis a’ 
vis stabilisation of the patient’s condition. 
We gave intravenously 4g (16 mmoles) of magnesium sulphate and 40 
millimoles of calcium gluconate in 0.9% saline over 24 hours. Within 2 days her 
serum calcium levels rose to 2.3 mmol/L, the magnesium stabilised at 0.89 
mmol/L after a transient overshoot the day before, with all other electrolytes 
settling as well. Clinically, her seizures resolved quite rapidly within a couple of 
hours of starting the 24 hour infusion, following which she remained seizure free. 
 
Electrolyte Baseline Day 1 (during infusion) Day 2 (post infusion) 
Urea (mmol/L) 7.6 6.9 6.7 
Creatinine (µmol/L) 106 108 102 
Sodium (mmol/L) 128 130 133 
Potassium (mmol/L) 3.3 3.6 3.9 
Calcium (mmol/L) 1.75 2.15 2.31 
Magnesium (mmol/L) 0.32 1.49 0.89 
Phosphate (mmol/L) 1.42 1.34 1.31 
 
 
Discussion 
 
Magnesium is the second most abundant intracellular cation in humans and is 
involved in numerous biological processes. The kidney and intestinal tract are the 
principal organs involved in magnesium homeostasis. Although calcium is 
considered to be the major regulator of parathyroid hormone (PTH) secretion, a 
number of studies have demonstrated that magnesium can modulate PTH 
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intracellular magnesium depletion impairs the ability of the parathyroid glands to 
secrete PTH resulting in a fall in the serum PTH levels, and subsequently a fall 
in the serum calcium concentration [7]. 
With their seminal 1976 publication Rude et al. (1976) studied seventeen 
patients suffering from this condition in an attempt to determine the 
pathogenesis of hypomagnesaemia-induced hypocalcaemia. They selected 
participants with a mean initial serum calcium concentration of 1.7-1.9 mmol/L, 
whilst their mean initial serum magnesium concentration was 0.3-0.4 mmol/L. 
Serum immunoreactive parathyroid hormone (IPTH) was measured in sixteen 
patients in the untreated state. Despite their severe hypocalcaemia, serum IPTH 
was either undetectable (less than 150 pg/ml) or normal (less than 550 pg/ml) in 
all but two patients, hinting at a paradoxically impaired PTH release with failure 
of the PTH negative feedback loop [2,8].  
We postulate that this patients’ long-term high dose bumetanide (4mg daily) 
had resulted in severe hypocalcaemia and hypomagnesaemia following salt (or 
sodium) wasting in the nephron, thus negating the nephron of its capacity to 
reclaim these cations from the urinary filtrate. Renal calcium and magnesium 
reabsorption both rely on the pump mediated influx of sodium from urinary 
filtrate with subsequent drawing in of water, which in turn carries calcium and 
magnesium ions with it (a process known as solvent drag) via the paracellular 
route in the thick ascending limb of the loop of Henle and distal convoluted 
tubule [1,5]. Conversely, in this case, the natriuretic action of bumetanide results 
in all these other cations being washed out in tandem with sodium within the 
urinary filtrate [1,5]. 
Albeit not in possession of a formal PTH level we found ample evidence in the 
literature that low magnesium effectively leads to a state of functional 
hypoparathyroidism and this is a well recognised phenomenon. It is known that 
magnesium is crucial in formation of cyclic AMP (adenosine monophosphate) 
both in the parathyroid glands as well as in their end-organs, such that both 
synthesis and secretion of PTH would be impaired [7], whilst it’s activity at end 
organs would be blunted, in the face of a low magnesium [7,9,10,11]. We surmise 
that failure of the parathyroid mechanism to reabsorb calcium from the bone, 
intestines and nephron (via activation of a specific calcium pump) dangerously 
lowered the serum calcium level which was producing seizure activity. It follows, 
from such a functional hypoparathyroid state, that one might expect to find 
either a slightly low or possibly a normal PTH level upon serum testing, since 
there is both an absolute as well as a relative PTH deficiency, given that the 
circulating PTH is unable to carry out fully its action on end organs at a PTH-
receptor level, even if this hormone is present in sufficient quantities, when 
contending with hypomagnesaemia. Moreover this ‘reduced sensitivity’ of PTH at 
effector end organs (gut enterocytes, nephron tubule cells and osteoclasts) might 
actually stimulate further hormone release from the parathyroid glands in an 
effort to overcome this partial metabolic block and the resultant calcium wastage 
(or persistence of hypocalcaemia) by means of its negative feedback loop 
mechanism.  
Treatment with intravenous calcium and magnesium allowed the calcium level 
to normalize, leading to rescindment of the neuromuscular hyperexcitability and 
resolution of the epilepsy. Phosphate level normalized (from its borderline high 
level) as well, indicating that the parathyroid dysfunction had resolved. The 
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magnesium level initially overshot the upper limit of normal but rapidly 
redistributed to within the normal range within 24 – 48 hours. The patient was 
maintained on oral magnesium supplementation (magnesium citrate tablets at 
300mg daily) so as to avoid recurrence of this phenomenon [6]. 
 
 
Learning Points 
 
1. Hypomagnesamia causes functional hypoparathyroidism. 
 
2. Resistant hypocalcaemia merits a search for underlying hypomagnesaemia. 
 
3. Long term loop diuretics is a leading cause of cation (including magnesium) 
depletion in the elderly. 
 
4. Always exclude electrolyte disturbances with seizures, particularly if the 
jerking is myoclonic in nature and there is no clouding of consciousness. 
 
5. Magnesium and calcium rapidly redistribute to the musculoskeletal system so 
any overshoot during intravenous administration is transient and rapidly 
buffered. 
 
 
 
References: 
 
1. Human Physiology, 2nd revised edition 1989, Chapter 30; Function of the kidneys. Schmidt R 
and Thews G, Springer Verlag publishers. 
2. Clin Endocrinol (Oxf). 1976 May;5(3):209-24. Functional hypoparathyroidism and parathyroid 
hormone end-organ resistance in human magnesium deficiency. Rude RK, Oldham SB, 
Singer FR. 
3. Magnesium depletion and hypermagnesaemia. In Primer on Metabolic Bone disease and disorders 
of mineral metabolism. 4th Ed. MJ Favus, Lippincot 1999;241-45. 
4. Hypomagnesaemia masquerading as hypoparathyroidism. J Assoc Physicians India. 2006 
May;54:411-2. Singh R, Bhat MH, Bhansali A. 
5. Quamme GA. Renal Magnesium handling, New insights in understanding old problems. Kidney 
Int 1997;52: 1180-95 
6. Abbott LG, Rude RK. Clinical manifestation of magnesium deficiency. Mineral, Electrolyte 
Metab 1993;19:290-95. 
7. Petts JT. Diseases of Parathyroid gland. Hyper and hypocalcemic disorders. In: Harrison’s 
principles of Internal Medicine. Eds. Braunwald, Fauci A et al; McGraw Hill, 2001; 2220-26 
8. Rude et al., 1976 as found in John P. Bilezikian,  Lawrence G. Raisz,  Gideon A. Rodan - 2002 -
  Medical; Mg Depletion and Parathyroid Gland Function 
9. Hypomagnesemia-induced hypocalcemia: functional hypoparathyroidism, parathyroid hormone- 
and vitamin D-resistant. Klin Wochenschr. 1990 Jul 5;68(13):678-84. Leicht E, Biro G, 
Keck E, Langer HJ.  
10. Magnesium Research journal. Mechanisms of hypocalcaemia in the clinical form of severe 
magnesium deficit in the human. 1992 Mar;5(1):37-44. Leicht E, Biro G. 
11. Hypomagnesemic hypocalcemia. Early serum calcium and late parathyroid hormone increase 
with magnesium therapy. Arch Intern Med. 1977 Jul;137(7):953-5. Wiegmann T, Kaye M. 
 
